Panbela Therapeutics, Inc. Short Interest Update

PBLADelisted Stock  USD 2.06  0.11  5.07%   
About 62% of Panbela Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Panbela Therapeutics stock suggests that many investors are alarmed at this time. The current market sentiment, together with Panbela Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Panbela Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
Panbela Therapeutics, Inc. was the recipient of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 150,700 shares, a decrease of 63.9 percent from the January 15th total of 417,700 shares. Currently, 2.5 percent of the companys shares are sold short. Based on an average

Read at thelincolnianonline.com
news
  

Panbela Therapeutics Fundamental Analysis

We analyze Panbela Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Panbela Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Panbela Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Employees

Number Of Employees Comparative Analysis

Panbela Therapeutics is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Panbela Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Panbela Therapeutics stock to make a market-neutral strategy. Peer analysis of Panbela Therapeutics could also be used in its relative valuation, which is a method of valuing Panbela Therapeutics by comparing valuation metrics with similar companies.

Peers

Panbela Therapeutics Related Equities

CYTOAltamira Therapeutics   7.50   
0%
86.0%
QNRXQuoin Pharmaceuticals   1.69   
0%
19.0%
PALIPalisade Bio   1.65   
0%
19.0%
UNCYUnicycive Therapeutics   1.47   
0%
16.0%
REVBRevelation Biosciences   1.33   
0%
15.0%
SONNSonnet Biotherapeutics   2.28   
26.0%
0%
CDIOCardio Diagnostics   3.23   
37.0%
0%
ZVSAZyVersa Therapeutics   3.60   
41.0%
0%
VRAXVirax Biolabs   4.83   
55.0%
0%
KPRXKiora Pharmaceuticals   8.68   
100.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Consideration for investing in Panbela Stock

If you are still planning to invest in Panbela Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Panbela Therapeutics' history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets